Loading Results

Research

Showing   of 171 results

Majid Jafar thumbnail photo

Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council

Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation.

Harrington Discovery Institute exterior

Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines.

Madison Conces, MD thumbnail image

UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.

Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.

Exterior photo of UH Portage Medical Center building

UH Harrington Heart & Vascular Institute at UH Portage Medical Center Study Shows Improved Patient Cardiovascular Outcomes

Enhanced access to cardiovascular care reduces ischemic heart disease mortality in rural Ohio.

Owen Witte, MD thumbnail image

International Harrington Prize Awarded to Dr. Owen Witte

2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies.

Drs. Remy and Mazer thumbnail

UH Rainbow Receives Grants from the Society of Critical Care Medicine to Study Severe Bronchiolitis

UH Rainbow Babies & Children’s Hospital has received two grants from SCCM to study the pathobiological factors and mechanistic underpinnings underlying severe bronchiolitis and sepsis.

Dr. Grace McComsey headshot

New Scientific Research Sheds Light on the Role of Vitamins K2 MK-7 and D3 in Alleviating Long COVID Symptoms

A groundbreaking clinical trial conducted by University Hospitals and published in the peer-reviewed journal Nutrients has revealed that a daily dose of vitamin D3 and vitamin K2 MK-7 could help improve symptoms of long COVID.

David Wald, MD, PhD thumbnail image

Research Team from Wesley Center for Immunotherapy at UH Seidman Cancer Center Awarded Top Scoring Abstract Award at the 2025 International Society for Cell and Gene Therapy Annual Meeting

Dr. David Wald and his colleagues selected for their abstract "Development and Clinical Validation of a Less Than One Day CAR T-cell Therapy Manufacturing Process".

Results are loading...